DKK3 and systemic lupus erythematosus: Given all these considerations, while kidney biopsy remains the gold standard for diagnostic and prognostic assessment in LN, if confirmed in a larger cohort, DKK3 could represent an additional useful prognostic tool to monitor patients with SLE and eventually guide therapeutic choices.